Langerhans cell histiocytosis manifesting at birth: a neonatal case with BRAF V600E mutation. [PDF]
Tang W, Wang P.
europepmc +1 more source
A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer [PDF]
Baranski, Thomas +8 more
core +1 more source
A Robust Immunohistochemistry-Based Classification for BRAF V600E-Mutant Colorectal Cancer With Clinical Implications. [PDF]
Liu C +11 more
europepmc +1 more source
Vemurafenib, cetuximab and camrelizumab in BRAF V600E-mutated/MSS metastatic colorectal cancer. [PDF]
Wei GX +6 more
europepmc +1 more source
Cost-effectiveness of first-line encorafenib plus cetuximab with mFOLFOX6 in BRAF V600E-mutant metastatic colorectal cancer. [PDF]
Shu Y +7 more
europepmc +1 more source
Interpreting Deep Learning-Based Prediction of the BRAF V600E Mutation Using Diagnostic Whole Slide Images in Skin Cutaneous Melanoma. [PDF]
Rao VR, Nguyen V, Phung TL, Sukhadia SS.
europepmc +1 more source
Dose-Response Relationship Between BRAF V600E Abundance and Cervical Lymph Node Metastasis in Papillary Thyroid Cancer. [PDF]
Yalikun Y +6 more
europepmc +1 more source
Dabrafenib plus trametinib in an elderly patient with BRAF V600E-mutant advanced pancreatic adenocarcinoma: A case report. [PDF]
Liu L +5 more
europepmc +1 more source
Precision targeted-immunotherapy for BRAF V600E and MET-amplified biliary tract cancer: two case reports. [PDF]
He X +5 more
europepmc +1 more source
Predicting BRAF V600E variants: yet another new method
openaire +2 more sources

